3-((4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)dimethylsilyl)propan-1-ol

ID: ALA5198099

Chembl Id: CHEMBL5198099

PubChem CID: 168289062

Max Phase: Preclinical

Molecular Formula: C14H18F6O2Si

Molecular Weight: 360.37

Names and Identifiers

Canonical SMILES:  C[Si](C)(CCCO)c1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1

Standard InChI:  InChI=1S/C14H18F6O2Si/c1-23(2,9-3-8-21)11-6-4-10(5-7-11)12(22,13(15,16)17)14(18,19)20/h4-7,21-22H,3,8-9H2,1-2H3

Standard InChI Key:  KNLLYRSQGRCDFQ-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5198099

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 360.37

Molecular Weight (Monoisotopic): 360.0980

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Namba N, Noguchi-Yachide T, Matsumoto Y, Hashimoto Y, Fujii S..  (2022)  Design, synthesis and structure-activity relationship of 4-(1,1,1,3,3,3-hexafluoro-2-hydroxyisoprop-2-yl)phenylsilane derivatives as liver X receptor agonists.,  66  [PMID:35576658] [10.1016/j.bmc.2022.116792]

Source

Source(1):

• Scientific Literature